Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
with therapeutic innovation and biotech development. The ICT team of the VIB-UGent Center for Inflammation Research (IRC) in Zwijnaarde is looking for a motivated and service-oriented IT Helpdesk
-
candidates to join us starting autumn 2026! Our different research groups explore how the brain and nervous system develops, ages and functions in health and disease, in particular neurodegenerative and
-
of biosamples from neurodegenerative disease patients and healthy controls and will assist with the development and execution of custom genetic assays aimed at novel gene discovery. Routinely used techniques will
-
initiative investigating how human-specific features of brain development shape early behavior and neural circuit function in autism spectrum disorders (ASD). This position is a joint effort between the
-
Learning Expertise Unit at VIB.AI. Your role As an LLM Engineer, you will: Develop and deploy pilot projects in close collaboration with and tailored to VIB’s domain-specific centers, applying LLMs
-
departments; building strong relationships with translational stakeholders, including academic hospitals, universities and research organizations; developing VIB-wide supportive activities related
-
in healthy states, genetically perturbed states, and during liver regeneration. On the other hand, you will develop algorithms to disentangle direct intercellular signals from those that are induced
-
Advanced Grant (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in liver macrophages in vivo. We will apply these technologies to unravel
-
Saelens team. Research Project In this research project you will develop probabilistic deep-learning models that automatically extract biological and statistical knowledge from in vivo perturbational omics
-
. The candidate will work in a team of scientists dedicated to develop antisense oligonucleotides as disease-modifying therapeutics for neurodegenerative diseases. Our strategy is based on an innovative, all-in